Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study

A drug repurposing strategy could be a potential approach to overcoming the economic costs for diabetes mellitus (DM) treatment incurred by most countries. DM has emerged as a global epidemic, and an increase in the outbreak has led developing countries like Mexico, India, and China to recommend a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chittepu, Veera C. S. R., Kalhotra, Poonam, Osorio-Gallardo, Tzayhri, Gallardo-Velázquez, Tzayhri, Osorio-Revilla, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572294/
https://www.ncbi.nlm.nih.gov/pubmed/31108878
http://dx.doi.org/10.3390/pharmaceutics11050238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572294/
https://www.ncbi.nlm.nih.gov/pubmed/31108878
http://dx.doi.org/10.3390/pharmaceutics11050238

Ejemplares similares